WEST LAFAYETTE, Ind., Aug. 3, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Mike Sherman, Chief Financial Officer of Endocyte, will present at the upcoming Canaccord Genuity 31st Annual Growth Conference on Tuesday, August 9, 2011 at 4:30 PM EDT in the San Francisco Room. The conference is being held at the InterContinental Boston in Boston, Massachusetts.
